Press "Enter" to skip to content

U.S. Hospital Pharmaceuticals to Reach US$280.3Billion

Pharmaceuticals drugs are sold through various channels such as retail, mail orders, clinics and hospitals. The report on the global hospital Pharmaceuticals market researches the current and future idea of the market specifically about drugs sold in hospital settings. The report includes an elaborate summary, including a market snapshot that provides overall information of various segments and sub-segments.

The research is a combination of primary and secondary research. The Primary research includes the bulk of our research efforts with information collected from telephonic interviews and interactions via e-ma. Secondary research involved a study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ million for each segment for the period from 2013 to 2023, considering the macro and micro environmental factors. The Growth rates for each division within the global teleradiology market have been determined after the analysis of past trends, demographics, future trends, technological developments, and regulator requirements.

Market revenue in terms of US$ Mn for the period between 2013 and 2023 along with the compound annual growth rate from 2015 to 2023 are provided for all the segments, considering 2014 as the base year. The global hospital Pharmaceuticals drugs market is segmented that includes cardiology, oncology, nephrology and urology, neurology, pain and infection. Cardiology division is divided into anti-hypertensive drugs, dyslipidemia drugs, and others. Oncology division is further divided into immunomodulating agents, alkylating agents, anti-metabolites, hormonal agents, and miscellaneous drugs. The Nephrology and urology segment is further divided into diuretic drugs, anti-hypertensive agents, phosphate binders, anticholinergic agents and 5-alpha-reductase inhibitors. The neurology segment is divided into anti-anxiety, anti-migraine, antidepressant and antipsychotic drugs.

The market for pain management drugs has been divided into anticonvulsant drugs, anaesthetics, nonsteroidal anti-inflammatory drugs, opioids, and non-narcotic analgesic drugs. Similarly, the anti-infective drugs market has been segmented into antibacterial drugs, antiviral drugs, anti-fungal drugs and anti-parasite drugs.

Be First to Comment

Leave a Reply

Your email address will not be published.